Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
-784K
-
Total reported value, excl. options
-
$3.36B
-
Value change
-
-$21.5M
-
Put/Call ratio
-
0.65
-
Number of buys
-
98
-
Number of sells
-
-81
-
Price
-
$27.24
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q4 2021
225 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q4 2021.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 211M outstanding shares and own 58.47% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (15.3M shares), VANGUARD GROUP INC (11.1M shares), BlackRock Inc. (9.32M shares), JANUS HENDERSON GROUP PLC (7.88M shares), Palo Alto Investors LP (6.03M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (4.91M shares), STATE STREET CORP (4.35M shares), AMERIPRISE FINANCIAL INC (4.16M shares), FMR LLC (3.55M shares), and Bellevue Group AG (3.52M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.